Nonselective beta-blocker use is associated with increased hepatic encephalopathy-related readmissions in cirrhosis

BACKGROUND: Hepatic encephalopathy (HE) is a neurocognitive condition in cirrhosis leading to frequent hospitalizations. Nonselective beta-blockers (NSBBs) are the mainstay of pharmacologic treatment in cirrhotic patients. We hypothesized that since NSBBs decrease cardiac output and portal flow, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fallahzadeh, Mohammad Amin, Asrani, Sumeet K, Tapper, Elliot B, Saracino, Giovanna, Rahimi, Robert S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403687/
https://www.ncbi.nlm.nih.gov/pubmed/36159543
http://dx.doi.org/10.12998/wjcc.v10.i23.8097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403687/
https://www.ncbi.nlm.nih.gov/pubmed/36159543
http://dx.doi.org/10.12998/wjcc.v10.i23.8097

Ejemplares similares